-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0136_07-21-2009.pdf
January 01, 2009 - It has been suggested that it is the most common indication for
referral to women's health services.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/angina-heart-attack-treatments_research-protocol.pdf
December 11, 2012 - Pantoprazole
Omeprazole
Lansoprazole
Rabeprazole
Esomeprazole
• For patients with indication … triple
therapy, defined as dual antiplatelet therapy in patients with UA/NSTEMI who also have an
indication … • In patients with an indication for oral anticoagulant therapy, what are the risks and
benefits of … In patients with an indication for long-term anticoagulant therapy, what are the
comparative effectiveness … twice daily Oral (an
intravenous
formulation is
commercially
available)
Approved No approved indication
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/progestogens-preterm-birth_executive.pdf
September 01, 2012 - Within each KQ, we organized the evidence by
aspects of the question, such as indication and formulation … One unique
indication, asymptomatic short cervix, had a randomized
trial of progesterone vaginal gel … after completion of our initial systematic review, bringing
the total number of women studied for this indication … Our update
identified eight additional randomized trials, one for the
indication of prior preterm birth … Use of progestogens for this indication is based on
evidence of moderate strength, based on small numbers
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/rapid-assessment-research-updates_research.pdf
September 15, 2008 - , as well as the identification of potential safety issues
and whether new evidence suggests a new indication … for a treatment or a new treatment for an existing
indication. … New
indication for
existing or
new
treatment
Still valid Possibly
out of date
Probably out … New
indication for
existing or
new
treatment
Still valid Possibly
out of date
Probably out … New
indication for
existing or
new
treatment
Still valid Possibly
out of date
Probably out
-
effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/pdf/epc-ki-tep-confidentiality-form-fillable.pdf
August 01, 2020 - If
they agree to provide comments, comments will be de-identified such that there will be no
indication
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0174_10-20-2009.pdf
January 01, 2009 - There is some indication that
non-pharmacologic therapies are underutilized in patients with OA and
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/rfviia.pptx
May 01, 2010 - of potential uses—prophylaxis, treatment, and end-stage—whereas the bar representing the off-label indication … Applicability diminished by mismatch between existing research and real-world patterns of indication … thereby compromised by small study size, use of indirect outcomes, and heterogeneity in dosage and indication … Mean Differences in Mortality and Thromboembolic Event Rates by Study and rFVIIa Indication
This figure … but failed to show an effect of rFVIIa on other outcomes, including mortality. rFVIIa use for this indication
-
effectivehealthcare.ahrq.gov/sites/default/files/rfviia.pptx
May 01, 2010 - of potential uses—prophylaxis, treatment, and end-stage—whereas the bar representing the off-label indication … Applicability diminished by mismatch between existing research and real-world patterns of indication … thereby compromised by small study size, use of indirect outcomes, and heterogeneity in dosage and indication … Mean Differences in Mortality and Thromboembolic Event Rates by Study and rFVIIa Indication
This figure … but failed to show an effect of rFVIIa on other outcomes, including mortality. rFVIIa use for this indication
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/kidney-disease-medicine_executive.pdf
January 01, 2012 - from CKD screening
requires that the treatment benefits CKD populations who
3
would have had no indication … for such treatment in the
absence of CKD or that, among patients with an indication
for the treatment … Patients with
hyperlipidemia and no coronary artery disease may
not otherwise have an indication for … Patients with systolic CHF already have an
indication for beta blockers, regardless of whether
they … However, as
patients with systolic CHF already have an indication for
beta blocker treatment, testing
-
effectivehealthcare.ahrq.gov/sites/default/files/s143.pdf
October 01, 2007 - Objectives: We sought to evaluate the ability of propensity score
matching to mitigate confounding by indication … Chief among them is the indication for the
drug—a patient must have the condition for which the drug … -
lished.16,17 We sought to demonstrate what might happen
when attempting to address confounding by indication … However, observational studies
of efficacy must address concerns of bias—especially con-
founding by indication
-
effectivehealthcare.ahrq.gov/sites/default/files/covariate-selection-chapter-7.pptx
January 01, 2013 - Provider actions
Confounding by indication: Prescribers choose treatments for patients who they believe … Sources of Confounding
Sources of Confounding
Provider Actions
Confounding by indication
Also referred … to as “channeling bias,” confounding by indication is common and often difficult to control in comparative … Confounding by indication and channeling over time: the risks of beta 2-agonists. … Confounding by indication: the case of calcium channel blockers.
-
effectivehealthcare.ahrq.gov/sites/default/files/developmental-delays-horizon-scan-high-impact-1306.pdf
June 01, 2013 - Manufacturers may have pursued regulatory
approval of intranasal oxytocin for this indication, but … care for treating social dysfunction in ASDs, given the absence of other medication options
for this indication … Laboratories, Ltd., of Tokyo, Japan, may have pursued regulatory approval of intranasal
oxytocin for this indication … about a potential disparity in the use of the intervention in
female patients (because an approved indication
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-194-evidence-summary-corticosteroids-asthma.pdf
October 01, 2017 - In this report, controller medications are defined by
the timing and indication for use rather than … Likewise, for this report, quick relief therapy is defined by
the timing and indication for use rather
-
effectivehealthcare.ahrq.gov/sites/default/files/llewellyn-thomas.pdf
January 01, 2011 - .
• End result is indication
of pt.’s overall favored option, at either the “coarse-‐grained” or … www.effectivehealthcare.ahrq.gov/index.cfm) �
• End result is also an indication
-
effectivehealthcare.ahrq.gov/sites/default/files/dementia-horizon-scan-high-impact-1412.pdf
February 01, 2015 - disease (AD), leading
investigators to study serotonin-boosting drugs, such as citalopram, for this indication … searches of American and international
registries found no significant ongoing clinical trials for this indication … Without
additional clinical data, off-label use may be limited for this indication. … may address this
unmet need, as a well-tolerated, potentially disease-modifying treatment for this indication … changes observed during intravenous
administration.4,10 Consequently, most clinical trials for this indication
-
effectivehealthcare.ahrq.gov/sites/default/files/depression-horizon-scan-high-impact-1312.pdf
October 01, 2014 - FDA has granted fast-track status for this indication. … receptor might prevent excessive cortisol activity, potentially
relieving PMD symptoms.11 For this indication … FDA has granted the agent fast-track status for this indication.1 FDA approved
Korlym in 2012 for treating … These payers consider mifepristone investigational
or unproven for this indication and do not provide … Manufacturers of scopolamine do not appear to be
pursuing an official indication for treating depression
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/observational-research-scores_research.pdf
May 01, 2012 - ................................................................................. 1
Confounding by Indication … Confounding by Indication
Confounding by indication is a specific type of confounding that is commonly … In some cases confounding by indication can be intractable. … Another problem with addressing confounding by indication arises when the indications are
not adequately … Since LDL level is a primary indication for statin therapy and higher
LDL levels are anticipated to
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/antibiotics-respiratory-infection_research-protocol.pdf
September 22, 2014 - Key Question 2: For patients with an acute respiratory tract infection (RTI) and no clear
indication … Key Question 3: For patients with an acute respiratory tract infection (RTI) and no clear
indication … Key Question 4: For patients with an acute respiratory tract infection (RTI) and no clear
indication … sinusitis; cough and
common cold.4
2) Parents of pediatric patients with acute RTI and no clear indication … indication!
for!antibiotics!
2)!Adults!and/or!
children!without!
acute!RTI!
3)!Clinicians!in!
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/stem-cell-children_research-protocol.pdf
November 01, 2010 - The role of HSCT in pediatric diseases
depends in part on the indication for which it is being used. … PICOTS
Indication 1. … of HSCT; quality of life (QOL)
T: All durations of follow-up will be included
S: Inpatient
Indication … Level of Evidence for the Narrative Reviews by Indication
Disease Type Supporting Literature
Malignant … Is the treatment setting for the particular disease indication included in the
systematic review?
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/medication-therapy-management-1_research.pdf
July 01, 2012 - o Medication List – regroup by indication, in medical as well as layman’s terminology. … o Regroup by indication, in layman’s terminology. … Is the drug dose form not appropriate for the
indication? (2.2)
c. … Is there no clear indication for use of the drug
in this patient? (2.5)
f. … Is there an untreated indication for which drug
therapy is available?